Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Proton beam and chemo combo tested for tough pancreatic cancer

NCT ID NCT03652428

First seen Mar 06, 2026 · Last updated May 24, 2026 · Updated 12 times

Summary

This study is for people with locally advanced pancreatic cancer that cannot be removed by surgery. It tests a new approach: giving two chemotherapy drugs (nab-paclitaxel and gemcitabine) at the same time as a precise, high-dose type of radiation called proton therapy. The main goal is to find the safest dose of the chemotherapy when used with this radiation. Participants will receive proton therapy every weekday for three weeks and chemotherapy once a week during that time.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED PANCREATIC CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • MedStar Georgetown University Hospital

    RECRUITING

    Washington D.C., District of Columbia, 20007, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Maryland Medical Center/Maryland Proton Treatment Center

    RECRUITING

    Baltimore, Maryland, 21201, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.